Buy TRACON Pharmaceuticals Stock | TCON Stock Price & Latest News | Public.com
TCON

TRACON Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View TRACON Pharmaceuticals (TCON) stock trends here

    About TCON

    TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treat...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.13
    -0.25
    -0.38
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.31

    Actual EPS
    Q2 2021

    Stats

    Market Cap$103,72M
    Volume11,01k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.20
    1 Year Low$1.55
    Open$6.17
    High$6.31
    Low$6.17

    Buy any stock with any amount of money.

    Download the App
    Download the app